GSK
-
Franchise India Bureau Sep 29 2017 - 1 min readGlobal healthcare company, GlaxoSmithKline Pharmaceuticals is investing Rs 1000 crore in a new state-of-the-art pharmaceutical unit in Karnataka and is looking at enhancing its global pipeline in areas like respiratory drugs and vaccines in India."We are investing Rs 1000 crore in a new state-of-the- art pharmaceutical factory in Vemgal, Karnataka. The factory will initially supply ...
